| Shareholders' equity |
Shareholders’ equity All of Chubb’s Common Shares are authorized under Swiss corporate law. Though the par value of Common Shares is stated in Swiss francs, Chubb continues to use U.S. dollars as its reporting currency for preparing the Consolidated Financial Statements. Under Swiss corporate law, dividends, including distributions from legal reserves or through a reduction in par value (par value reduction), must be stated in Swiss francs though dividend payments are made by Chubb in U.S. dollars. At September 30, 2026, our Common Shares had a par value of CHF 0.50 per share.
At our May 2026 annual general meeting, our shareholders approved an annual dividend for the following year of up to $4.08 per share, expected to be paid in four quarterly installments of $1.02 per share after the general meeting by way of distribution from capital contribution reserves, transferred to free reserves for payment. The Board of Directors (Board) will determine the record and payment dates at which the annual dividend may be paid until the date of 2027 annual general meeting, and is authorized to abstain from distributing a dividend at its discretion. At our May 2025 and 2024 annual general meetings, our shareholders approved annual dividends for the following year of up to $3.88 per share and $3.64 per share, respectively, which were paid in four quarterly installments of $0.97 and $0.91 per share, respectively, at dates determined by the Board after the annual general meetings by way of a distribution from capital contribution reserves, transferred to free reserves for payment.
The following table presents dividend distributions per Common Share in Swiss francs (CHF) and U.S. dollars (USD):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30 | | September 30 | | 2026 | | 2025 | | 2026 | | 2025 | | CHF | | USD | | CHF | | USD | | CHF | | USD | | CHF | | USD | | Total dividend distributions per common share | 0.83 | | | $ | 1.02 | | | 0.78 | | | $ | 0.97 | | | 2.38 | | | $ | 3.01 | | | 2.40 | | | $ | 2.85 | |
Increases in Common Shares in treasury are due to open market repurchases of Common Shares and the surrender of Common Shares to satisfy tax withholding obligations in connection with the vesting of restricted stock and the forfeiture of unvested restricted stock. Decreases in Common Shares in treasury are principally due to grants of restricted stock, exercises of stock options, purchases under the Employee Stock Purchase Plan (ESPP), and share cancellations. During March 2026 and 2025, Chubb completed share capital reductions by means of cancellation of 11,986,574 and 7,518,565 Common Shares purchased under our share repurchase program during 2025 and 2024, respectively. The capital reductions were completed in accordance with the capital band provision for authorized share capital increases and reductions by the Board set forth in the Articles of Association. During the nine months ended September 30, 2026, 9,927,161 shares were repurchased, 11,986,574 shares were canceled, and 1,356,003 net shares were issued under employee share-based compensation plans. At September 30, 2026, 17,590,778 Common Shares remain in treasury.
Chubb Limited securities repurchase authorizations In June 2023, the Board authorized the repurchase of up to $5.0 billion of Chubb Common Shares, effective July 1, 2023, with no expiration date. In May 2025, the Board determined to terminate the June 2023 authorization as of June 30, 2025 and concurrently authorized a new repurchase amount of up to $5.0 billion of Chubb Common Shares, effective July 1, 2025, with no expiration date. In May 2026, the Board determined to terminate the June 2025 authorization as of June 30, 2026 and concurrently authorized a new repurchase amount of up to $7.5 billion of Chubb Common Shares, effective July 1, 2026, with no expiration date. The following table presents repurchases of Chubb's Common Shares conducted in a series of open market transactions under the Board authorizations:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | October 1, 2026 through October 27, 2026 | | September 30 | | September 30 | | | (in millions of U.S. dollars, except share data) | 2026 | | 2025 | | 2026 | | 2025 | | | Number of shares repurchased | 3,419,780 | | | 4,436,315 | | | 9,927,161 | | | 8,121,824 | | | 876,400 | | | Cost of shares repurchased | $ | 1,177 | | | $ | 1,232 | | | $ | 3,299 | | | $ | 2,293 | | | $ | 305 | | | Repurchase authorization remaining at end of period | $ | 6,327 | | | $ | 3,783 | | | $ | 6,327 | | | $ | 3,783 | | | $ | 6,024 | | The following table presents changes in accumulated other comprehensive income (loss): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30 | | September 30 | | (in millions of U.S. dollars) | 2026 | | 2025 | | 2026 | | 2025 | | Accumulated other comprehensive income (loss) (AOCI) | | | | | | | | | Net unrealized appreciation (depreciation) on investments | | | | | | | | | Balance – beginning of period, net of tax | $ | (3,282) | | | $ | (2,772) | | | $ | (1,997) | | | $ | (4,552) | | | Change in period, before reclassification from AOCI (before tax) | (4,941) | | | 837 | | | (6,604) | | | 2,598 | | | Amounts reclassified from AOCI (before tax) | 105 | | | 31 | | | 299 | | | 157 | | | Change in period, before tax | (4,836) | | | 868 | | | (6,305) | | | 2,755 | | | Income tax (expense) benefit | 370 | | | (52) | | | 559 | | | (163) | | | Total other comprehensive income (loss) | (4,466) | | | 816 | | | (5,746) | | | 2,592 | | | Noncontrolling interests, net of tax | 9 | | | (16) | | | 14 | | | (20) | | | Balance – end of period, net of tax | (7,757) | | | (1,940) | | | (7,757) | | | (1,940) | | | Current discount rate on liability for future policy benefits | | | | | | | | | Balance – beginning of period, net of tax | (164) | | | (746) | | | (344) | | | (539) | | | Change in period, before tax | 300 | | | 305 | | | 541 | | | 53 | | | Income tax (expense) benefit | (51) | | | 26 | | | (120) | | | 47 | | | Total other comprehensive income | 249 | | | 331 | | | 421 | | | 100 | | | Noncontrolling interests, net of tax | (22) | | | 47 | | | (30) | | | 23 | | | Balance – end of period, net of tax | 107 | | | (462) | | | 107 | | | (462) | | | Instrument-specific credit risk on market risk benefits | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance – beginning of period, net of tax | (12) | | | (12) | | | (23) | | | (16) | | | Change in period, before tax | — | | | (9) | | | 13 | | | (4) | | | Income tax (expense) benefit | — | | | 2 | | | (2) | | | 1 | | | Total other comprehensive income (loss) | — | | | (7) | | | 11 | | | (3) | | | Noncontrolling interests, net of tax | — | | | — | | | — | | | — | | | Balance – end of period, net of tax | (12) | | | (19) | | | (12) | | | (19) | | | Cumulative foreign currency translation adjustment | | | | | | | | | Balance – beginning of period, net of tax | (3,015) | | | (2,919) | | | (3,135) | | | (4,025) | | | Change in period, before reclassification from AOCI (before tax) | 666 | | | 136 | | | 1,056 | | | 1,306 | | | Amounts reclassified from AOCI (before tax) | (11) | | | (8) | | | (31) | | | (23) | | | Change in period, before tax | 655 | | | 128 | | | 1,025 | | | 1,283 | | | Income tax (expense) benefit | 40 | | | (17) | | | 44 | | | (26) | | | Total other comprehensive income | 695 | | | 111 | | | 1,069 | | | 1,257 | | | Noncontrolling interests, net of tax | 56 | | | 49 | | | 310 | | | 89 | | | Balance – end of period, net of tax | (2,376) | | | (2,857) | | | (2,376) | | | (2,857) | | | Fair value hedging instruments | | | | | | | | | Balance – beginning of period, net of tax | (27) | | | (40) | | | (58) | | | 50 | | | Change in period, before reclassification from AOCI (before tax) | (9) | | | (17) | | | (36) | | | 98 | | | Amounts reclassified from AOCI (before tax) | 21 | | | 14 | | | 87 | | | (215) | | | Change in period, before tax | 12 | | | (3) | | | 51 | | | (117) | | | Income tax (expense) benefit | (3) | | | — | | | (11) | | | 24 | | | Total other comprehensive income (loss) | 9 | | | (3) | | | 40 | | | (93) | | | Noncontrolling interests, net of tax | — | | | — | | | — | | | — | | | Balance – end of period, net of tax | (18) | | | (43) | | | (18) | | | (43) | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30 | | September 30 | | (in millions of U.S. dollars) | 2026 | | 2025 | | 2026 | | 2025 | | Postretirement benefit liability adjustment | | | | | | | | | Balance – beginning of period, net of tax | 577 | | | 431 | | | 582 | | | 438 | | | Change in period, before tax | (5) | | | (3) | | | (11) | | | (10) | | | Income tax benefit | 1 | | | 1 | | | 2 | | | 1 | | | Total other comprehensive loss | (4) | | | (2) | | | (9) | | | (9) | | | Noncontrolling interests, net of tax | — | | | — | | | — | | | — | | | Balance – end of period, net of tax | 573 | | | 429 | | | 573 | | | 429 | | | Accumulated other comprehensive loss | $ | (9,483) | | | $ | (4,892) | | | $ | (9,483) | | | $ | (4,892) | | | | | | | | | |
The following table presents reclassifications from accumulated other comprehensive income (loss) to the Consolidated statements of operations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | Consolidated Statement of Operations Location | | September 30 | | September 30 | | | (in millions of U.S. dollars) | 2026 | | 2025 | | 2026 | | 2025 | | | Fixed maturities available-for-sale | $ | (105) | | | $ | (31) | | | $ | (299) | | | $ | (157) | | | Net realized gains (losses) | | Income tax (expense) benefit | 20 | | | (11) | | | 43 | | | 17 | | | Income tax expense | | $ | (85) | | | $ | (42) | | | $ | (256) | | | $ | (140) | | | Net income | | Cumulative foreign currency translation adjustment | | | | | | | | | | | Cross-currency swaps | $ | 11 | | | $ | 8 | | | $ | 31 | | | $ | 23 | | | Interest expense | | Income tax expense | (2) | | | (2) | | | (6) | | | (5) | | | Income tax expense | | $ | 9 | | | $ | 6 | | | $ | 25 | | | $ | 18 | | | Net income | | Net gains (losses) of fair value hedging instruments | | | | | | | | | | | Cross-currency swaps | $ | (16) | | | $ | (9) | | | $ | (73) | | | $ | 229 | | | Net realized gains (losses) | | Cross-currency swaps | (5) | | | (5) | | | (14) | | | (14) | | | Interest expense | | Income tax (expense) benefit | 4 | | | 3 | | | 18 | | | (45) | | | Income tax expense | | $ | (17) | | | $ | (11) | | | $ | (69) | | | $ | 170 | | | Net income | | Total amounts reclassified from AOCI | $ | (93) | | | $ | (47) | | | $ | (300) | | | $ | 48 | | | |
|